Form EFFECT Tempest Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NCLA Asks Fourth Circuit to Shutter FINRA’s Illegal ‘Private’ Enforcement Regime
- Ujjivan Small Finance Bank Revises USD FCNR(B) Deposit Rate to 7.50% p.a.
- Enhancing Roadway Safety: Deploying Pi-lit(R) Impact Detection Technology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share